Deutsche Bank Maintains a 'Buy' on Gilead Sciences (GILD); Weekly Scripts Tracking Ahead of Estimates
Tweet Send to a FriendGet Alerts GILD Hot Sheet
Price: $55.79 -0.91%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 12
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 12
Trade GILD Now!
Deutsche Bank maintains a 'Buy' on Gilead Sciences (NASDAQ: GILD) price target of $57.00.
Analyst, Robyn Karnauskas, said, "Analysis of IMS Weekly scripts for the week 13 of 2Q:12 (week 13 of 13) indicates that GILD’s HIV franchise at $1,097.8M is tracking $32.9M better than consensus ($1,064.9M)...Ex all price increases in 1Q, we project sales would be tracking to $1,092.8M or about $28.0M better than consensus (DB analysis and FactSet). Notably, Complera projected Q2 sales are $18.5M better than consensus with Atripla & Truvada also tracking better than consensus."
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $50.96 yesterday, with a 52 week range of $34.45-$56.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Robyn Karnauskas, said, "Analysis of IMS Weekly scripts for the week 13 of 2Q:12 (week 13 of 13) indicates that GILD’s HIV franchise at $1,097.8M is tracking $32.9M better than consensus ($1,064.9M)...Ex all price increases in 1Q, we project sales would be tracking to $1,092.8M or about $28.0M better than consensus (DB analysis and FactSet). Notably, Complera projected Q2 sales are $18.5M better than consensus with Atripla & Truvada also tracking better than consensus."
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $50.96 yesterday, with a 52 week range of $34.45-$56.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
- UPDATE: BTIG Starts ING U.S (VOYA) at Buy, Shares 'Significantly Undervalued'
- Wall Street Expresses Tepid Enthusiasm on Yahoo! (YHOO) / Tumblr Deal
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Retail SalesRelated Entities
Deutsche Bank, Raising Prices
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
